EXCITE Performance Measures Dataset in Extremity Constraint Induced Therapy Evaluation Trial

Results of the following measurements: Passive and active range of motion (ROM), expressed as degrees of extension and flexion; Fugl-Meyer Assessment (FMA), with variables based on weighted values; spatial perception tests, including star cancellation (measured as number of stars targeted, ranging 0 to 54) and letter cancellation (measured as number of letters crossed out, ranging 0 to 40); Modified Ashworth Scale (MAS), with scores of 0-4; number of falls experienced in the past year; Established Populations for Epidemiologic Studies of the Elderly (EPESE) protocol for balance, with scores of 0-4; 360-degree turn procedure, where values are captured as number of seconds it takes a participant to make a 360-degree turn; and general questions related to the use of assistive devices such as canes and wheelchairs
Study Description
The first national, randomized, single-blind study to systematically test a neurorehabilitation therapy - constraint induced movement therapy (CIMT) - among patients with the ability to initiate extension movements at the wrist and fingers and who had experienced a first stroke within 3 to 9 months prior to enrollment. Participants recruited from 247 clinics nationwide were randomized to receive CIMT to the more impaired upper extremity for two weeks upon enrollment or to receive the identical intervention 15-21 months post-stroke. Outcome measures were the Wolf Motor Function Test (WMFT) and Motor Activity Log (MAL) for functional improvements and the Stroke Impact Scale (SIS) for health-related quality of life.
Individuals with sub-acute (3-6 months post-insult) ischemic or hemorrhagic stroke